IOL Chemicals and Pharma gets EDQM certification to supply Pantoprazole Sodium Sesquihydrate in European market

7 Nov 2022 , 10:52 AM

IOL Chemicals and Pharmaceuticals Limited (IOL), a leading manufacturer of pharmaceutical (APIs) and specialty chemicals has announced receiving EDQM certification to supply Pantoprazole Sodium Sesquihydrate API across European market. Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress the gastric acid secretion.

As per the filing, the company started production of Pantoprazole Sodium Sesquihydrate in Q3 FY 2020 at its Punjab based facility. With this CEP certification, the Company will now be able to export it to entire Europe.

Further, IOL currently, has a total capacity of producing 240 TPA of Pantoprazole Sodium Sesquihydrate, the company mentioned in a filing.

Notably, IOL is the world largest producer of Ibuprofen API with 33% market share globally. The Company has 13 plus APIs in its portfolio such as Metformin Hydrochloride, Clopidogrel Bisulfate Form II, Fenofibrate, Paracetamol etc.

At around 10:55 AM, IOL Chemicals & Pharmaceuticals Ltd is currently trading at Rs373.10 per share up by Rs2.85 or 0.77% from its previous closing of Rs370.25 per share on the BSE.

For feedback and suggestions, write to us at [e-mail]